Education
About Us
Working with TipRanks
Follow Us
Kronos Bio, Inc. (KRON)
:KRON
See the Price Targets and Ratings of:
KRON Financial Forecast
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
Piper Sandler
$1
Hold
14.94%
Upside
Downgraded
11/14/24
Kronos Bio downgraded to Neutral from Overweight at Piper SandlerKronos Bio downgraded to Neutral from Overweight at Piper Sandler
H.C. Wainwright
$2.25
Buy
158.62%
Upside
Reiterated
08/19/24
Analysts' Opinions Are Mixed on These Healthcare Stocks: Kronos Bio (NASDAQ: KRON), Spruce Biosciences (NASDAQ: SPRB) and scPharmaceuticals (NASDAQ: SCPH)
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
Piper Sandler
$1
Hold
14.94%
Upside
Downgraded
11/14/24
Kronos Bio downgraded to Neutral from Overweight at Piper SandlerKronos Bio downgraded to Neutral from Overweight at Piper Sandler
H.C. Wainwright
$2.25
Buy
158.62%
Upside
Reiterated
08/19/24
Analysts' Opinions Are Mixed on These Healthcare Stocks: Kronos Bio (NASDAQ: KRON), Spruce Biosciences (NASDAQ: SPRB) and scPharmaceuticals (NASDAQ: SCPH)
KRON Analyst Recommendation Trends
Rating
Jul 24
Aug 24
Oct 24
Nov 24
Jan 25
Strong Buy
3
4
4
3
1
Buy
1
1
1
1
0
Hold
0
0
0
2
3
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
4
5
5
6
4
Each month's total comprises the sum of three months' worth of ratings.
KRON Stock Forecast FAQ
What is KRON’s average 12-month price target, according to analysts?
Based on analyst ratings, Kronos Bio, Inc.’s 12-month average price target is $1.00.
What is KRON’s upside potential, based on the analysts’ average price target?
Kronos Bio, Inc. has 14.94% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is KRON a Buy, Sell or Hold?
Kronos Bio, Inc. has a consensus rating of Hold which is based on 0 buy ratings, 0 hold ratings and 0 sell ratings.
What is Kronos Bio, Inc.’s price target?
The average price target for Kronos Bio, Inc. is $1.00. This is based on 0 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $1.00 ,the lowest forecast is $1.00. The average price target represents 14.94% Increase from the current price of $0.87.
The highest analyst price target is $1.00 ,the lowest forecast is $1.00. The average price target represents 14.94% Increase from the current price of $0.87.
What do analysts say about Kronos Bio, Inc.?
Kronos Bio, Inc.’s analyst rating consensus is a Hold. This is based on the ratings of 0 Wall Streets Analysts.
How can I buy shares of KRON?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.